IL-1β induces tumor angiogenesis through activation of the vascular endothelial growth factor pathway, increases immunosuppressive cells, and accelerates tumor invasion via secretion of GM-CSF and IL-6 [15] [17, 18]. Here, VEGFA is linked to neoplasm.